Description
Release form
Solution for oral administration
Packing
200 ml in a dark glass bottle, equipped with a measuring cap. The bottle contains a label, which is a folded inside instructions for use. Each bottle is placed in a cardboard box along with instructions for use.
Pharmacological action
Combined preparation, the pharmacological activity of which is due to its constituent extract components based on medicinal plant materials with a predominantly sedative (calming) effect and guaifenesin. possessing anxiolytic (anti-anxiety) effect.
Contraindications
Pregnancy, breast-feeding, individual intolerance to the components of Nervo-Vit.
Use during pregnancy and lactation
During pregnancy, the drug is prescribed only if absolutely indicated if the expected effect for the mother outweighs the possible risk to the fetus.
If you need to use the drug during lactation, breastfeeding should be discontinued.
Ingredients
Active ingredients:
Novo-Passita extract liquid (obtained from rhizomes with Valerian roots, Melissa officinalis herb, St. John’s wort perforated, Common leaves and common leaves) incarnate (passionflower), common hops fruit, black elderberry flowers) 7.75 g Guaifenesin – 4.00 g in 100 ml
solution Excipients:
sodium cyclamate, xanthan gum, invert sugar syrup, atria benzoate, sodium saccharin monohydrate, ethanol 96%, orange flavor, sodium citrate dihydrate, maltodextrin, propylene glycol, purified water.
Dosage and administration of
Nervo-Vit take orally. 2-3 tablets 3 times a day with meals.
Duration of admission: 2 weeks. Before use, it is recommended to consult a doctor.
Side effects
Allergic reactions.
Drug Interactions
With the simultaneous administration of Novo-Passit ® and other drugs, their effect may be enhanced or weakened. Before you start taking the drug at the same time as other drugs, you should consult your doctor.
The drug enhances the effects of alcohol and other substances that inhibit the central nervous system.
Medicines, used to relax skeletal muscles (central muscle relaxation), can increase the risk of side effects of the drug, especially muscle weakness.
St. John’s wort extract contained in the preparation reduces the effectiveness of hormonal contraception, as well as drugs used mainly after transplantation to reduce the risk of rejection of the transplanted organ or tissue (immunosuppressive drugs), drugs intended for the treatment of AIDS, cardiovascular diseases, bronchial diseases and prevention thromboembolism. Therefore, before taking Novo-Passit ® against the background of these drugs, you must consult your doctor.
Overdose
Overdose is initially manifested by feeling overwhelmed and drowsy. Later, these symptoms may be accompanied by nausea, mild muscle weakness, joint pain, and a feeling of heaviness in the stomach. If symptoms of overdose appear, the drug should be discontinued. Treatment is symptomatic. You should consult a doctor.
Storage Conditions
In a dark place at a temperature not exceeding 25 ° C.
Shelf life
2 years.
Deystvuyushtee hdlkp hawthorn flowers and leaves, hawthorn fruits, guaifenesin, St. John’s wort, hops, melissa, passionflower,
Conditions for dispensing from pharmacies
Without a prescription
dosage form orally prdrok17 drufflfprd dpf69 solution for oral administration oral solution
Possible product names
Novo-Passit 200.0ml
Novo-Passit 200ml srdlkl Nrd Prd rd pld rplkp Nrd NOVO-PASSIT 200ML FLAC RR R D / RECEPTION INSIDE
NOVO-PASSIT 200ML. RR FL.
Teva Pharmaceutical Enterprises Ltd., Israel
